During early embryogenesis of both vertebrates and invertebrates, antagonism between bone morphogenetic proteins (BMPs) and several unrelated secreted factors including Chordin (Chd) is a general mechanism by which the dorso-ventral axis is established. High af®nity binding of Chd sequesters the BMP ligands in the extracellular space, preventing interactions with their membrane receptors. Another level of regulation consists in processing of vertebrate Chd or its Drosophila counterpart Sog by astacine metalloproteases like Xolloid-BMP-1/ Tolloid, respectively, which releases an active BMP. Recently, it was shown that cleavage of Sog by Tolloid could generate novel BMP inhibitory activity and that sog is also capable of stimulation of BMP activity in a tolloid-dependant way. Activity and/or cleavage of Chd/ Sog are in¯uenced by other secreted factors like twisted gastrulation. In this study, we have cloned cDNAs of the human chordin gene (CHRD) and characterized alternative splice variants that code for C-truncated forms of the protein. We have found that CHRD is expressed in fetal as well as in adult tissues with relatively high levels in liver, cerebellum and female genital tract, suggesting functions in late embryogenesis and adult physiology. We also show that spliced variants are present with speci®c patterns in various tissues. When tested in an axis-duplication assay in Xenopus, we ®nd that these variants can antagonize BMP activity. Altogether, these results suggest that, in addition to processing by metalloproteases, alternative splicing (AS) is another mechanism by which sub-products of CHRD can be generated to in¯uence BMP activity in different developmental and physiological situations. q
Introduction
Bone morphogenetic proteins (BMPs) are signalling molecules that play essential roles during metazoan development. Their importance in morphogenesis and organogenesis has been clearly established from studies of BMPde®cient animals (Hogan, 1996a,b) . In the adult, they are involved in various processes such as bone remodelling and repair, wound healing, hematopoiesis, immune and in¯am-matory response, neuronal plasticity and ovary physiology (Hogan, 1996a; Mehler et al., 1997; Shimasaki et al., 1999) . Like other growth factors, their activity depends on interactions with components of the extracellular matrix, which regulate their regional localization as well as their state of activation (Taipale and Keski-Oja, 1997; Park et al., 2000) .
In vertebrates, a number of extracellular antagonists of BMPs have been described, such as Chordin, Noggin, Follistatin or DAN family members (DAN, Cerberus and Gremlin), which directly bind their BMP targets (Piccolo et al., 1996; Zimmerman et al., 1996; Fainsod et al., 1997; Hsu et al., 1998; Piccolo et al., 1999) .
In Xenopus embryos, while BMPs are initially expressed uniformly in the gastrula, a gradient of activity of BMP-4 along the dorso-ventral (D-V) axis is thought to result in part from interactions with these antagonists, locally secreted by the dorsal lip or Spemann's organizer and that would be capable of diffusion into the adjacent sectors of the marginal zone, resulting in the patterning of the mesoderm (reviewed in Dale and Jones, 1999) . In addition, antagonists of BMP-4 issued from the organizer contribute to neural differentiation of the adjacent ectoderm .
Some insight about the in vivo functions of these multiple BMP binding proteins in vertebrates is brought by analysis of the phenotypes of mutants. In zebra®sh, expression patterns, overexpression studies and analysis of mutants show that chordin opposes BMP-2/-4 and -7 ventralizing signals at gastrulation (reviewed in Kodjabachian et al., 1999; Dick et al., 2000) . Similarly in chick, mis-expression experiments show that BMP-4 and chordin also oppose during gastrulation, but chordin is not suf®cient for neural induction (Streit et al., 1998) .
In the Drosophila embryo, D-V axis is also determined through interactions between sog, a BMP-2/-4 homologue decapentaplegic (dpp) (Padgett et al., 1987; Ferguson and Anderson, 1992b; Franc Ëois et al., 1994; Biehs et al., 1996) and a BMP-5 to -8 homologue screw (scw) (Arora et al., 1994; Neul and Ferguson, 1998; Nguyen et al., 1998) . sog is expressed ventrally and promotes development of the neuroectoderm by protecting the ventral zone from BMP dorsalizing activity issued from the adjacent dorsal territory (Franc Ëois et al., 1994; Biehs et al., 1996) . Paradoxically, mutant phenotype and BMP signalling chasing indicate that sog is also required for BMP peak activity in the most dorsal region of the embryo (Zusman et al., 1988; Ferguson and Anderson, 1992a; Franc Ëois et al., 1994; Dorfman and Shilo, 2001 ). To explain this activity, it was proposed that Sog diffuses in the dorsal region where it would bind to BMPs and promote their accumulation more dorsally thanks to the release of active BMP after cleavage of Sog into inactive products from Sog±BMP complexes by the dorsally expressed astacin metalloprotease Tolloid (Tld) (Marques et al., 1997) . In vertebrates, the related proteases, Xenopus Xolloid (Xld) and BMP-1 as well as mammalian Tolloid-like 1 (mTLL-1) and BMP-1 all oppose chordin activity in Xenopus secondary axis induction assays and cleave Chd in vitro (Piccolo et al., 1997; Scott et al., 1999; Wardle et al., 1999; Blitz et al., 2000) . In the Xenopus embryo, they are uniformly expressed during blastula and gastrula stages and have been proposed to constitute the`sink' required for a graded distribution of Chd. Tld proteases cleave Chd/Sog at two and three sites, respectively, and if Chd is prebound to BMPs, cleavage results in the release of active BMPs (Piccolo et al., 1997) . It is not known whether cleavage products have speci®c functions in vivo. Sog/Chd are large proteins with four Cys-rich repeats (CR1±4) of about 70 amino acids each related to domains found in procollagen (Franc Ëois et al., 1994; Sasai et al., 1994) . Although the overall structures of Sog and Chd are analogous , the sequence conservation between Sog and Chd is only 26% with higher scores between the CRs (up to 50% for CR1). Nevertheless, the mechanism of action between sog and chordin have been conserved during the course of evolution and both genes have comparable activity when cross-tested in Drosophila and Xenopus (Holley et al., 1995; Schmidt et al., 1995) . In a structure±function analysis, it was recently shown that Chd's ability to bind to BMPs resides in the CRs and that individual CR repeats still inhibit BMP signalling, but with a lesser ef®ciency than full-length protein . Recently, another extracellular factor, Drosophila Twisted gastrulation (Tsg) (Mason et al., 1994) and its vertebrate counterparts have been shown to in¯uence the cleavage of Sog/Chd by proteases and to modify the interactions of Sog/Chd and cleavage products with BMPs (Oelgeschlager et al., 2000; Yu et al., 2000; Chang et al., 2001; Ross et al., 2001; Scott et al., 2001) .
Only little information is available concerning the possible roles of chordin beyond early axis-formation in vertebrates. In zebra®sh, a later role in skeletal patterning has been assigned to chordin (Fisher and Halpern, 1999) . In mouse, targeted inactivation of chordin has been reported to result in stillborn animals with normal early development but with later defects in ear development, pharyngeal and cardiovascular organization . The complex and dynamic expression pattern during mouse embryogenesis also suggests multiple roles for this gene, including for squelettogenesis and organogenesis, as well as in the adult (Scott et al., 2000) .
In this study, we report extensive analysis of human chor- Fig. 1 . Sequence analysis of cDNAs of full-length and splice variants of the CHRD. The sequence coding for the full-length chordin gene was determined from three overlapping cDNAs. The 450 bp on the 5 H end only are derived from a single cDNA. Translation initiating ATG and termination TGA or TAG codons are in bold. The polyadenylation site is underlined. The predicted translation initiating ATG is preceded by CGTC (boxed), which conforms relatively well to the Kozak consensus (CANC) for a vertebrate translation start site (Cavener, 1987) . In the 955 amino acids predicted protein, we ®nd two discrepancies with the published sequence of Smith et al. (1999) : they are amino acids 9±11 (APL instead of PRV) and amino acids 40±50 (KEPLPVRGAAG instead of RSR.CRSGSGS). The mouse sequence for these two polypeptides is APR and KEPLPVRGAAG, respectively (Pappano et al., 1998) . The arrowhead after residue 26 marks the signal peptide cleavage site predicted by the SignalP program from the Center for Biological Sequence Analysis (CBS). The four Cys-rich domains of CHRD are boxed and shaded grey. Five potential N-glycosylation sites (N-X-S/T) are bold and underlined. Two of these sites, at positions 351 and 434, are conserved in Xenopus, zebra®sh and chick and mouse (Pappano et al., 1998) , suggesting possible functional signi®cance. Alternative spliced cDNAs are also represented. Arrows indicate position of introns involved in their occurrence. Nucleotides in lower case correspond to intron sequence near the exon junctions (Smith et al., 1999) , as well as internal sequence of intron 2 deduced from comparison with the genomic sequence 5
H of the THPO gene (Kamura et al., 1997) . Presumed splice donor (gt) and acceptor (ag) sites are underlined. Two cDNAs corresponding to AS involving intron 2 are represented (variants 1 and 2). They both retained a sequence internal to intron 2 (boxed)¯anked by consensus donor and acceptor splice sites. Presence of in frame stops codons in the alternative exons of these variants results in abortive CHRD proteins in CR1 domain. A cDNA lacks 29 nucleotides (between brackets) in the 5 H end of exon 9 (variant 3). This short deletion probably results from splicing between donor site of intron 8 and acceptor site on the 3 H end of the deleted segment. It results in a frame shift causing abortive translation as shown, giving rise to a form containing CR1 plus 225 amino acids of the 578 residues of the inter-region between CR1 and CR2. A cDNA isolated from infant brain lacks exon 19 (deletion of 104 nucleotides; variant 4). The resulting partial CHRD protein is interrupted just before CR3. Two cDNAs have in frame deletions of exon 12 (120 nucleotides, variant 5) or exon 16 (264 nucleotides, variant 6). They code for proteins with internal deletions (dotted lines) of 40 and 88 residues, respectively. din cDNAs and characterization of alternatively spliced mRNAs encoding predicted truncated forms of the protein.
We analysed the expression of CHRD in fetal and adult tissues and also examined the existence of these mRNA variants in different adult tissues where CHRD expression was detected. In order to determine whether these variants have a functional signi®cance, we tested their biological activity in a Xenopus axis duplication assay.
Results

Characterization of cDNAs and genomic mapping of CHRD
The human EST AA036834 from Soares pregnant uterus library was ®rst selected on the basis of the similarity of its predicted polypeptide with Xenopus Chd (xChd). Sequencing of the corresponding cDNA revealed a putative ORF of 170 amino acids aligning with the C-terminal region of Xenopus chordin containing the Cys-rich CR3 and CR4 domains. The sequence also contains 0.5 kb of untranslated DNA that ends with a polyadenylation tract. We hybridized this cDNA to human tissue Northern blots in order to ®nd a tissue where the gene was expressed. As strong expression was found in fetal liver, we screened a fetal liver cDNA library with this cDNA as a probe. Several overlapping cDNAs expanding from 1.2 kb on the 5 H end of the initiator codon down to the polyadenylation sequence were analysed. The complete coding sequence that we determined is in good accordance with the recently published sequence for the same gene deduced from a combination of genomic sequencing and RT-PCR analysis (Smith et al., 1999) , except for two regions in the 160 bp following the ATG (see legend of Fig. 1 ). Pairwise comparison at the protein level shows a higher degree of identity in the regions of discrepancy between the sequence we describe here and mouse chordin sequence (Pappano et al., 1998) .
We performed a genomic localization of the CHRD locus by FISH using a 100 kb PAC genomic clone, which revealed a unique signal at position 3q27 (data not shown), which con®rms previous localization obtained by hybrid radiation mapping (Pappano et al., 1998) . From sequence analysis, Smith et al. (1999) placed CHRD and thrombopoõ Èetin (THPO) promoters within a 2 kb interval. CHRD ATG is located at 1320 and 2130 bp from the two possible transcription starts of THPO, respectively (Chang et al., 1995; Kamura et al., 1997) . Although the transcription start of the CHRD gene is not known, the size of the largest transcripts we detect by Northern blot indicates that the divergent genes CHRD and THPO have their 5
H -UTR overlapping.
CHRD is expressed in fetal and adult tissues
CHRD expression was analysed by hybridizing a large panel of fetal and adult tissues on Northern blots with a cDNA probe spanning most of the coding region of the gene. A major transcript of 7 kb is detected in adult and 24-week-old fetus liver (Fig. 2a,e) . Another ,3.5 kb transcript is predominant in female genital tract (uterus, cervix and ovary) (Fig. 2b) and a ,4 kb transcript is found in cerebellum (Fig. 2c) . Most regions of the brain (Fig. 2c,d ) and all fetal tissues examined (Fig. 2e) contain this transcript, although at much lower levels. For higher sensitivity and speci®city, we re-hybridized all the blots with an antisense RNA probe. In addition to the already described transcripts, this probe revealed a new transcript of 7.5 kb in adult heart and squeletic muscle, and in fetal muscle, as well as a weak ,3.5 kb species in medulla and spinal cord (data not shown). The presence of different transcripts could result from the use of alternative promoters and/or different polyadenylation signals. This last hypothesis is unlikely as all cDNAs considered with a polyA have the same sequence at their 3 H end. Alternatively, the different mRNAs could arise by alternative splicing (AS). The gene contains 22 introns in the coding region (Smith et al., 1999) and additional introns in the 5 H untranslated region (our observation). Nevertheless, all the mRNAs species we detect by Northern blot are large enough to contain the complete coding sequence and thus code for the full-length Chd protein.
Alternative splicing generates putative truncated or internally deleted forms of CHRD with speci®c patterns of expression
In addition to the sequence coding for the entire CHRD protein, analysis of cDNAs revealed the presence of several splice variants (Fig. 1) . All cDNA variants we describe here can be interpreted as AS events that occur at the exon±intron junctions. Two variants (variants 1 and 2) correspond to AS in intron 2. In both cases, an internal fragment of this intron anked by typical eucaryotic donor and acceptor sites has been kept in these cDNAs. This fragment introduces a stop codon close to the foregoing exon. The proteins predicted for variants 1 and 2 are short truncated forms of CHRD, with only a part of CR1 (P-CR1; Fig. 3 ). Another variant (variant 3) has a deletion at the 5 H end of exon 9 and can be interpreted by occurrence of a splicing event between the donor site of intron 8 and an acceptor site inside exon 9. The deduced protein contains the CR1 domain followed by a part of the region between CR1 and CR2 (CR1-PIR (IR, inter-repeat); Fig. 3 ). In addition to cDNAs isolated from the fetal liver library, we also examined the sequence of a 1540 bp cDNA from infant brain identi®ed by database searching (Genbank accession No. AF038198). This cDNA (variant 4) has a complete deletion of exon 19 and encodes a putative truncated CHRD protein interrupted just before CR3 (CR1-IR-CR2; Fig. 3 ). Two partial CHRD cDNAs have been described by others, which lack exon 12 (AF076612; Pappano et al., 1998; variant 5) or exon 16 (Smith et al., 1999; variant 6) . The predicted proteins encoded by these two variants have internal deletions of 40 and 88 residues, respectively (Fig. 1) .
Due to small differences in size, Northern blots did not permit to discriminate between splice variants. To gain further evidence of their existence, we realized RT-PCR experiments on tissues in which CHRD expression is observed by Northern blot. Primers¯anking each variable region were used to amplify CHRD cDNA reverse-transcribed from fetal liver, as well as adult liver, ovary and cerebellum. In all cases, a fragment corresponding to the canonical spliced form of chordin was observed (Fig. 4) , suggesting that a typical full-length protein is produced in these tissues. Conversely, two variant forms were detected with speci®c patterns. The PCR fragment corresponding to variant 1/2 was found only in fetal and adult livers. The PCR fragment for variant 3 was found in all individual ovary samples tested, but neither in liver nor in cerebellum. PCR pro®les for variants 4 and 6 were found in all tissues analysed, whereas no fragment corresponding to variant 5 was detected in these tissues (Fig. 4) . These results suggest that truncated or deleted forms of CHRD are associated with the full-length protein in various combinations, typical of the tissue where the gene is expressed.
Predicted truncated forms of CHRD have biological activity
We reconstituted a full-length CHRD cDNA by joining two overlapping cDNAs at an appropriate restriction site. We also generated cDNAs containing each variable region by replacing a short DNA fragment with convenient restriction sites in this construct. We tested for activity of the fulllength CHRD cDNA and variants that code for the truncated proteins in a dorsalizing assay in Xenopus embryos. Injections of sog/chordin mRNAs in the presumptive ventral mesoderm before gastrulation changes ventral identity to a more dorsal fate as a result of blocking endogenous BMP signalling, leading to the formation of a secondary axis (Sasai et al., 1994; Holley et al., 1995; Schmidt et al., 1995) .
We performed injections with different doses of mRNA for each construct, each dose corresponding to equimolar amounts of mRNA (see legend of Fig. 5) . Ventral injections of 100 pg of full-length CHRD mRNA resulted in tadpolestage embryos with a secondary dorsal axis (Fig. 5b) typical of blocking of BMP activity. The partially duplicated axis rarely displayed a cement gland at the anterior end and always lacked a complete head structure. Embryos injected with high amounts of RNA (5 ng) had very short trunks and large head and cement gland and can thus be interpreted as dorso-anteriorized embryos. In the same assay, we did not observe any activity for P-CR1 mRNAs, even at a high dose (5 ng) (data not shown). This result shows that P-CR1, which has only four Cys, does not constitute a functional module with detectable anti-BMP activity in this assay. mRNAs of the two other truncated forms of CHRD, which contain one or two CR repeats induced partial Fig. 2 . Northern blot analysis of the human chordin expression. Northern blots were hybridized with a CHRD cDNA probe. In adult tissues (a±d), three major transcripts are detected migrating at ,7, ,3.5 and ,4 kb in adult liver (a), female genital tract (b) and cerebellum (c), respectively. Besides cerebellum, a very weak signal at 4 kb is detected in all parts of the brain (c,d). In fetal tissues (e), a major ,7 kb transcript is found in liver and a minor 4 kb transcript appears in brain and liver. Fetus age in weeks is: brain, 20; liver, 24; lung, 37 and muscle, 28. Each lane contains 2 mg of polyA 1 mRNA. At the bottom of each blot, the hybridization signal with a GAPDH DNA probe is shown as a control for mRNA integrity and loading. secondary axis formation (Fig. 5a,b) . They are less active than full-length CHRD in this assay, as secondary partial axis started to be observed at a dose (600 pg) where the maximum percentage of embryos with secondary axes was already obtained with full-length CHRD. A higher mRNA dose (1 ng) gave secondary axis at high frequency with both truncated forms (Fig. 5a) . Surprisingly, CR1-PIR, which has only one CR repeat was signi®cantly more active than CR1-IR-CR2. This higher activity is revealed both by the extent of the induced partial axis and by the frequency of this phenotype (Fig. 5a,b) . Altogether, these results indicate that AS generates in vivo truncated forms of CHRD with biological activity and that at least one complete CR repeat is required for activity.
Discussion
Activity of truncated forms
We provide evidence that in vivo processing of the human chordin transcript generates splice variants with biological activity. The predicted proteins translated from the variants we have tested display the same N-terminus part of Chd, including the signal peptide and differ in length on the C-terminus side. They appear as truncated forms of CHRD containing either a part of CR1 (P-CR1), CR1 and part of the inter-repeat (CR1-PIR), or CR1 and CR2 repeats with the intervening region (CR1-IR-CR2). Beside fulllength CHRD, the two forms containing CR1 can induce secondary axis in Xenopus embryos. At equimolar levels, CR1-PIR mRNA has about 10 times less activity than the full-length protein mRNA. This ratio is comparable to what was recently reported for individual CR1 versus full-length mouse Chordin (mChrd) in the same Xenopus assay . The authors have shown that the IR alone has no activity in this assay and that CR1 has eight times less af®nity for BMP-4 than full-length Chd (Piccolo et al., 1996; Larrain et al., 2000) . From this, we infer that most of the biological activity we detect in this assay for CR1-PIR is due to the binding of CR1 to BMPs. For each CR, the percentage of identity for mChrd and CHRD, respectively, compared to xChd is: CR1, 65 and 67; CR2, 69 and 71; CR3, 82 and 81; CR4, 50 and 50. Furthermore, with only very few exceptions, the amino acids at the same positions are conserved between the three species. As the degree of conservation for each CR between the orthologous proteins is almost the same when comparing mouse and human with Xenopus, it is valid to compare different constructs between human and mouse.
We do not exclude that CR1-PIR may have an activity unrevealed by the Xenopus dorsalizing assay. This form is very similar to a recently described Sog cleavage product referred as Supersog, whose occurrence in vitro depends on the presence of extracellular Tsg (Yu et al., 2000; Fig. 3) . Similarly to what we observe with human CR1-PIR when compared to full-length CHRD, Supersog is less active than Sog at inducing secondary axis in Xenopus embryos (Yu et al., 2000) , but in Drosophila, Supersog induces a stronger phenotype than Sog in the wings, when mis- Fig. 3 . Schematic representation of full-length CHRD and truncated proteins. The top line represents CHRD cDNAs as described in Fig. 1 . Predicted full-length and truncated proteins are represented underneath. Partial CR1 (P-CR1), CR1 1 partial inter-repeat (CR1-PIR) and CR1 1 inter-repeat 1 CR2 (CR1-IR-CR2) correspond to the predicted proteins from splice variants 1/2, 3 and 4, respectively. P-CR1 contains six of the 10 Cys found in each CR domain. The black box represents the signal peptide. Cleavage sites (arrows) of Chd (above) and of Sog (below) by Tld and related proteases are represented on full-length Chd. Dotted lines arrows represent Tsg-dependant cleavage sites for Sog (Yu et al., 2000) and for Chd (Scott et al., 2001 ). expressed during development. Yu et al. (2000) present genetic evidence that the Supersog activity is due to Supersog having dpp as a BMP target, in addition to the presumed Sog target Glass-bottom-boat (Gbb/60A), an orthologue of vertebrate BMP-5 to -8 (Wharton et al., 1991; Doctor et al., 1992) . It is thus tempting to speculate that truncated forms of CHRD may have a wider BMP target range than the full-length protein, not revealed in the Xenopus assay. As axis duplication is observed upon injection of these forms, we infer that they still behave as BMP antagonists, although weaker (i.e. having a lower af®nity for the BMP ligand) than the fulllength Sog/Chd proteins. In addition to requirement for a proper BMP target, a`superchordin' behaviour of CR1-PIR may only be obtained in the presence of other factors. For example, in addition to modifying Chd cleavage in vitro, Tsg increases the secondary axis-inducing activity of Chd and particular products of Chd cleavage (Scott et al., 2001) .
Surprisingly, CR1-IR-CR2 is two to three times less active than CR1-PIR. By analogy with the difference observed between mouse Chrd and individual CRs , we expected that a form having CR1 and CR2 would have more af®nity for BMP-4 than a form with CR1 only, and thereby be more potent in the axis duplication assay. We cannot exclude that this difference in activity re¯ects a difference in protein amounts due to unequal translation or stability of the truncated proteins. As an alternative, we propose that the conformation of CR1-PIR-CR2 is such that binding of each CR of one molecule on a BMP-4 dimer is exclusive, whereas full-length Chd could contact a BMP-4 dimer by multiple CRs, as proposed previously . As CR2 has a lower af®nity for BMP-4 than CR1, the resulting apparent af®nity would be lower for CR1-PIR-CR2 compared to CR1-PIR. Alternatively, when present at the C-terminal end of the protein, CR2 may negatively interfere with the binding of CR1 to BMP-4, either by a direct effect on the conformation of the molecule or by binding with some other extracellular matrix component, rendering CR1 less prone to BMP-4 binding.
The shorter form with only part of CR1 did not show any activity in the axis duplication assay suggesting that a fulllength CR is probably the minimum module of Chd capable of anti-BMP activity. Insofar as this short form of CHRD and full-length CHRD are co-expressed at similar mRNA levels in fetal and adult livers, we supposed that P-CR1 may have an anti-morphic effect on CHRD. To test this hypothesis, we injected P-CR1 mRNAs in the dorsal marginal zone where chordin is normally expressed at the onset of gastrulation. We detected no phenotype by the tadpole stage (data not shown), which indicates that P-CR1 is neither an antagonist of chordin nor a BMP-4 agonist.
Possible functional implications of CHRD expression
Due to its expression in fetal tissues, chordin is susceptible to have functions during human postgastrulation development. A role for mouse chordin in organogenesis and skeletogenesis was proposed in view of its expression in the primordia of most organs and in differentiating cartilage (Scott et al., 2000) . In situ hybridization on a human embryo at Carnegie stage 20 gave us similar results, with especially strong expression in condensing cartilage (unpublished data). As BMPs are involved in adult physiology, a function for BMP inhibitors such as chordin can also be expected. Indeed, our Northern blot analysis revealed that chordin is expressed in adult tissues at a relatively high level. In the brain, we detect maximum expression in the cerebellum, a region of high synaptic plasticity, which involves BMP activity (reviewed in Mehler et al., 1997) . In postnatal mouse brain, cerebellum expression is also observed for chordin, abutting a BMP-3b expression domain, suggesting a role of these players in neuroplasticity (Scott et al., 2000) .
We detect CHRD transcripts in female ± but not male ± genital tract. This expression is of particular interest as, in rat ovaries, BMP-4 and BMP-7 are proposed to play a paracrine role involved in regulating FSH-induced steroidogen- RT-PCR experiments were carried out with total or polyA 1 RNA from adult tissues for which expression was detected on Northern blots. Individual tissue samples were used, except for cerebellum (pool of 11 samples). A PCR fragment corresponding to the full-length protein (star) was detected in each sample, for every combination of primers used. An arrow indicates the PCR fragments corresponding to each splice variant. The size of each PCR fragment in bp is shown on the left. Variant 5 was not detected in this assay. esis (Shimasaki et al., 1999) . CHRD may thus have a function in normal ovary physiology in the adult. Expression of CHRD in the liver bears the possibility that this factor is released into the general circulation and has functions in systemic cellular processes, such as hematopoiesis, immune or in¯ammatory responses in which BMPs are involved.
Signi®cance of chordin sub-products
In this study, we show that presumptive truncated forms of CHRD are generated by AS in vivo, including exon skipping, exon truncation and inclusion of sequences currently described as intronic. The mRNA variants of CHRD can be detected along with the`canonical' spliced mRNA corresponding region and this in a speci®c manner for several human adult tissues, such as liver, ovary and cerebellum. Therefore, it is likely that different combinations and/or proportions of full-length CHRD and sub-products are found in different cell types during development and in adult tissues. So far, AS has not been described in other species for chordin. This mechanism enables CHRD subproducts to be made with no need for cleavage by metalloproteases. It remains to be determined whether these products play a role in vivo. In a recent study, the involvement of CHRD in Cornelia de Lange syndrome (CDLS), characterized by frequent mental retardation and limb abnormalities, was excluded because no mutations were found in the exons of the gene (Smith et al., 1999) . The existence of splice variants raises the issue of possible mis-splicing events of CHRD in CDLS or other developmental syndromes. Mis-splicing could be caused by mutations in intronic sequences and could result in appearance or predominance of a speci®c splice variant leading to abnormal development.
Antagonism of BMPs may well not be the only function of Sog/Chd sub-products, as suggested by tld-dependant enhancement of dpp activity by sog (Ashe and Levine, 1999) . CR repeats of the type of Sog/Chd are found in an expanding family of secreted proteins. Among them, Drosophila Crossveinless 2 (Cv-2) is required for potentiating BMP signalling necessary for cross veins formation in the wing (Conley et al., 2000) , which shows that CR containing molecules can enhance BMP signalling instead of inhibiting it. Further analysis will be required to determine whether CHRD sub-products have other properties in speci®c extracellular situations.
Experimental procedures
Library screening, cloning and sequencing
A PAC human genomic library (obtained at the UK HGMP Resource Center) was hybridized with a 938 bp 32 P random prime radiolabelled cDNA probe made from Image clone EST#AA036834 that contains the 3 H end of chordin. Two positive overlapping clones were obtained from UK HGMP Resource Center. A human random primed fetal liver cDNA library in vector lambda-gt11 (Clontech) was screened with the same probe and the two largest isolated cDNAs were sequenced. To encompass all the coding sequence, the library was screened again with a 5 H end fragment of the longest cDNA. A full-length cDNA was reconstituted from two overlapping clones by use of a unique Xba1 site. DNA fragments from isolated splice variants cDNAs were replaced into this full-length cDNA by use of appropriate restriction sites.
Sequencing was performed on an ABI 373 automatic DNA sequencer (Applied Biosystems) using Dye Deoxy Terminator sequencing kits. Sequences of cDNAs corresponding to full-length chordin as well as variants 1, 2 and 3 have been deposited in Genbank with accession No. AF209928, AF209929, AF209930 and AF283325, respectively. A partial cDNA for variant 4 was obtained at the Image Consortium (AF038198).
Northern blot analysis
Multiple tissue Northern blots (human 12-lane and brain blots II and IV from Clontech) and Northern territory blots (human normal blot IV and human fetal blot I from Invitrogen) were simultaneously hybridized with a random prime 32 P radiolabelled CHRD 2.4 kb AvrII-Sma1 DNA fragment following manufacturer's recommendations (AmershamPharmacia Rediprimee II system). After stripping, we rehybridized the blots with a random primed 1 kb GAPDH DNA probe as a control. The blots were exposed for 4 days with the CHRD probe and for 5 h with the GAPDH probe. Fig. 5 . Activity of the different forms in the Xenopus dorsalization assay. (a) Frequency of secondary axis formation. Embryos were injected ventrally into two blastomeres at the four-or eight-cell stage with 5±10 nl of various concentrations of mRNAs. They were scored at tadpole stage as having one axis only or a partial secondary axis. Even very short axes were considered. For a given dose, synthetic RNAs of each variant were all injected in one experiment, repeated twice. Since all transcripts have approximately the same size (3.5 kb), each dose in mass corresponds to equimolar amounts of RNA molecules. Furthermore, all the constructs are identical (same 5 H -UTR, 3 H -UTR, initiation of translation) to the exception of the small exonic additions or truncations. Thus, it is likely that similar molar amounts of proteins are translated from each construct at a given dose. Percentage is the average of at least two experiments. Full-length CHRD (black bars) is compared to CR1-PIR (white bars) and CR1-IR-CR2 (grey bars). Ventral injections of the P-CR1 mRNA gave no axis duplication even at
